<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01206283</url>
  </required_header>
  <id_info>
    <org_study_id>030531674</org_study_id>
    <nct_id>NCT01206283</nct_id>
  </id_info>
  <brief_title>A Study Comparing Modified Lund Concept and Cerebral Perfusion Pressure-targeted Therapy in Secondary Brain Ischaemia.</brief_title>
  <official_title>Modified Lund Concept Versus Cerebral Perfusion Pressure-targeted Therapy: A Randomized Controlled Study in Patients With Secondary Brain Ischaemia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sarajevo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sarajevo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Secondary brain ischaemia (SBI) usually develops after aneurysmal subarachnoid haemorrhage&#xD;
      (SAH) and severe traumatic brain injury (TBI). The current management strategies are based on&#xD;
      intracranial pressure-targeted therapy (ICP-targeted) with cerebral microdialysis monitoring&#xD;
      (modified Lund concept) or cerebral perfusion pressure-targeted therapy (CPP-targeted). We&#xD;
      present a randomised controlled study to compare the two management strategies.&#xD;
&#xD;
      The hypotheses of the study were:&#xD;
&#xD;
        -  SBI developed after aneurysmal SAH and severe TBI share the same crucial characteristics&#xD;
           and any treatment applied will essentially treat the same underlying pathophysiology.&#xD;
&#xD;
        -  ICP-targeted therapy with cerebral microdialysis monitoring according to the modified&#xD;
           Lund concept is superior to CPP-targeted therapy in managing comatose patients with SBI&#xD;
           after aneurysmal SAH and severe TBI.&#xD;
&#xD;
      Sixty comatose operated patients with SBI following aneurysmal SAH and severe TBI were&#xD;
      randomized into ICP-targeted therapy with cerebral microdialysis monitoring and CPP-targeted&#xD;
      therapy groups. Mortality rates in both groups were calculated and biochemical signs of&#xD;
      cerebral ischaemia were analysed using cerebral microdialysis. Outcome for cerebral&#xD;
      microdialysis was measured as poor outcome (Glasgow Outcome Scale score 1, 2 and 3) or good&#xD;
      outcome (Glasgow Outcome Scale score 4 and 5).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>18 months</time_frame>
    <description>Measurement of outcome was done using the Glasgow Outcome Scale (GOS) after each specific intervention in all the patients. GOS 1 - dead, 2- vegetative, 3- severe disabled, 4- moderate disabled, 5- independent.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Brain Injuries</condition>
  <condition>Subarachnoid Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Cerebral perfusion pressure-targeted</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 comatose operated patients after aneurysmal subarachnoid haemorrhage and severe traumatic brain injury respectively were managed postoperatively using cerebral perfusion pressure-targeted therapy according to the American Associations of Neurological Surgeons. Results were categorised into different Glasgow Outcome Scores.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intracranial pressure-targeted therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Modified Lund concept</intervention_name>
    <description>After surgical evacuation of intracranial mass lesion and clipping of aneurysm the objectives were achieved:&#xD;
Reduction of cerebral energy metabolism with fentanyl (2-5 µg/kg/h) and thiopenthal (0.5-3 mg/kg/h);&#xD;
Maintenance of colloid osmotic pressure with administration of red cell and albumin/plasma transfusions to maintain Hb/s 125-140 g/L and Alb/s ≈40 g/L;&#xD;
Reduction of capillary hydrostatic pressure with α2-agonist clonidine (0.4-0.8 µg/kg, 1 x 4-6 iv.) and maintaining normovolaemia;&#xD;
Reduction of mean arterial pressure and neuroprotection with Nimodipine infusion 5 ml per hour for 21 days and Urapidil 200 mg /200 ml, 7-10 ml/h.&#xD;
Control of ICP, which can be in majority of patients, kept at values below 15 mmHg.</description>
    <arm_group_label>Intracranial pressure-targeted therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cerebral perfusion pressure-targeted therapy</intervention_name>
    <description>ICP monitoring using an external ventricular drain and CSF drainage as a first measure if ICP was increased (over 15-20 mmHg);&#xD;
Maintenance of CPP over 70-80 mmHg (Triple 'H' therapy = 3L/24 hours including 1L of colloids - 5% albumin; drugs = dopamine, dobutamine);&#xD;
No hyperventilation if ICP was under 20-25 mmHg and hyperventilation as a third measure if ICP was increased;&#xD;
Osmotherapy (20% manitol, bolus 150-350 ml or 10% manitol, 50 ml/h for 10 hours and standard electrolytes [Na, Cl and K]);</description>
    <arm_group_label>Cerebral perfusion pressure-targeted</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with subarachnoid haemorrhage who had anterior circulation aneurysm rupture&#xD;
             only&#xD;
&#xD;
          -  multiple anterior aneurysm rupture&#xD;
&#xD;
          -  severe traumatic brain injury with isolated head injury and intradural focal lesions&#xD;
             only&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Glasgow Outcome Score of 3 with or without brainstem reflexes&#xD;
&#xD;
          -  Significant co-morbidities&#xD;
&#xD;
          -  posterior circulation aneurysm&#xD;
&#xD;
          -  multisystem injuries&#xD;
&#xD;
          -  diffuse axonal injuries&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kemal Dizdarevic, MD, MSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurosurgery, Clinical Centre University of Sarajevo, Sarajevo, Bosnia and Herzegovina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurosurgery, Clinical Centre University of Sarajevo</name>
      <address>
        <city>Sarajevo</city>
        <zip>71000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bosnia and Herzegovina</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <study_first_submitted>September 20, 2010</study_first_submitted>
  <study_first_submitted_qc>September 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2010</study_first_posted>
  <last_update_submitted>September 20, 2010</last_update_submitted>
  <last_update_submitted_qc>September 20, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 21, 2010</last_update_posted>
  <responsible_party>
    <name_title>Kemal Dizdarevic</name_title>
    <organization>Clinical Center University of Sarajevo, Bosnia and Herzegovina</organization>
  </responsible_party>
  <keyword>traumatic brain injury</keyword>
  <keyword>subarachnoid hemorrhage</keyword>
  <keyword>secondary brain ischemia</keyword>
  <keyword>microdialysis</keyword>
  <keyword>modified Lund concept</keyword>
  <keyword>cerebral perfusion pressure</keyword>
  <keyword>intracranial pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

